{
  "drug_name": "Chloramphenicol",
  "tradename": "Chloromycetin",
  "drug_shortage": [
    {
      "preparation": "Injection",
      "start_date": "2023-10-09",
      "notes": ""
    }
  ],
  "usage_and_dosing": {
    "general": [
      "Chloramphenicol is available in IV or po form, but no oral preparation is distributed in the US.",
      "Used as an alternative antibiotic when less toxic agents are not effective.",
      "Alternative to Doxycycline for rickettsial infections.",
      "Alternative therapy for tularemia.",
      "Possible alternative for N. meningitidis or S. pneumoniae meningitis in patient with severe penicillin allergy.",
      "In extensive systematic review and meta-analysis of controlled trials, authors conclude that chloramphenicol cannot be recommended as preferred therapy for the treatment of respiratory tract infections, meningitis, or enteric fever (J Antimicrob Chemother 70: 979, 2015)"
    ],
    "adult_dose": {
      "usual_dose": "50-100 mg/kg/day po/IV, divided q6h (maximum of 4 gm/day)"
    },
    "pediatric_dose": {
      "dose_age_gt_28_days": "50-100 mg/kg/day IV (divided q6h)",
      "max_day": "2-4 gm"
    }
  },
  "renal_adjustment": {
    "notes": [
        "Body weight and Creatinine Clearance calculations",
        "CrCl = Creatinine clearance (mL/min)",
        "CAPD = Continuous Ambulatory Peritoneal Dialysis",
        "CRRT = Continuous Renal Replacement Therapy",
        "AD = after hemodialysis",
        "SLED = sustained low efficiency dialysis",
        "Dosage adjustment may be required in hepatic disease."
    ],
    "half_life_normal": "4.1",
    "half_life_esrd": "Unchanged",
    "dose_normal_function": "50-100 mg/kg/day po/IV (divided q6h)",
    "crcl_or_egfr": "No dosage adjustment for renal impairment",
    "hemodialysis": "No dosage adjustment",
    "capd": "No dosage adjustment",
    "crrt": "No dosage adjustment",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "note": "Monitor serum concentrations in hepatic dysfunction, if possible.",
    "mild_impairment_child_pugh_a": "Consider dosage adjustment",
    "moderate_impairment_child_pugh_b": "Consider dosage adjustment",
    "severe_impairment_child_pugh_c": "Consider dosage adjustment"
  },
  "adverse_effects": [
    "Fever, rash, neutropenia, thrombocytopenia, diarrhea, headache, confusion.",
    "Hematologic (↓ RBC ~1/3 patients; aplastic anemia 1:21,600 courses but may be fatal).",
    "Gray baby syndrome in premature infants (circulatory collapse).",
    "Other: anaphylactoid reactions, optic atrophy or neuropathy (very rare), digital paresthesias, minor disulfiram-like reactions."
  ],
  "pregnancy_risk": {
    "fda_risk_category": "C",
    "lactation": "Avoid use",
    "footnote": "Capital letter = Old FDA risk category; Text = New FDA risk category"
  },
  "antimicrobial_spectrum": {
    "preferred": [],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "No data",
    "preparations": "Injection (no po in US)",
    "food_recommendation": "Cap ± food",
    "oral_absorption_percent": "High",
    "tmax_hr": "No data",
    "peak_serum_conc_ug_ml": "18 (1 gm po q6h, SS)",
    "peak_urine_conc_ug_ml": "No data",
    "protein_binding_percent": "25-50",
    "volume_of_distribution_vd_l_kg": "0.8 L/kg",
    "avg_serum_half_life_hr": "4.1",
    "elimination": "Metabolized",
    "bile_penetration_percent": "No data",
    "csf_blood_percent": "45-89",
    "therapeutic_levels_in_csf": "Yes",
    "auc_ug_hr_ml": "No data"
  },
  "enzyme_interactions": {
    "cyp450_substrate": [],
    "transporter_substrate": [],
    "ugt_substrate": [],
    "cyp450_inhibited": ["CYP2C19", "CYP3A4"],
    "transporters_inhibited": [],
    "ugts_inhibited": [],
    "cyp450_induced": [],
    "transporters_induced": [],
    "ugts_induced": [],
    "serum_drug_concentration_impact": "↑"
  },
  "drug_interactions": [
    {
      "drug": "Iron salts",
      "effect": "↓ response to iron salts",
      "management": "Monitor"
    },
    {
      "drug": "Phenytoin",
      "effect": "↑ phenytoin",
      "management": "Monitor, adjust dosage"
    },
    {
      "drug": "Protease inhibitors (HIV)",
      "effect": "↑ chloramphenicol, ↑ protease inhibitor",
      "management": "Avoid co-administration"
    },
    {
      "drug": "Vitamin B12",
      "effect": "↓ response to vitamin B12",
      "management": "Monitor"
    }
  ],
  "comments": [
    "Used for severe infections when other alternatives are not available."
  ]
}
